AKT1 and cancer: A set of triterpenoids demonstrate the ability to reduce phosphorylation levels of the mechanistic target of rapamycin (mTOR) and mTOR/AKT/PI3K pathway that lead to delay in aging and aging-related disorders (including cancer and neurodegeneration) [262,282,283,284,285,286,287,288].